KR20030074946A
|
|
A method for the preparation of organic fluoro compounds
|
KR20030042373A
|
|
A method for preparing of chiral 2,2-dimethylcyclopropanecarboxyl derivatives
|
KR20030034287A
|
|
Preparation of Chiral Compounds by Asymmetric Ring Opening of Racemates
|
KR20030026654A
|
|
An antigen for production of an antibody against human rotavirus, and a preparing method and a use thereof
|
KR20030026653A
|
|
An antigen for production of an antibody against Propionibacterium acnes, and a preparing method and a use thereof
|
KR20030000779A
|
|
Transformation of Lansoprazole crystalline form and its Purification
|
KR20020092502A
|
|
Process for manufacturing the chiral compounds by asymmetric ring opening reaction of racemic Epichlorohydrin
|
KR20020074802A
|
|
Method for Preparing Powder of Egg Yolk Having IgY, Powder of Egg Yolk , and Compositions Comprising the Same
|
KR20020072642A
|
|
Purification process of clarithromycin
|
KR20020068592A
|
|
Method of Preparing Lansoprazole and Its Intermediate
|
KR20020028380A
|
|
Regulator of NO-mediated Apoptosis and method for regulating NO-mediated Apoptosis
|
KR20020016276A
|
|
Process for the preparation of terbinafine and its hydrochloride as an antifungal agent
|
KR20010087482A
|
|
A producing method of conjugate specific immunoprotein against five species of microbes inducing gastritis and duodenal ulcer
|
KR20010081232A
|
|
Method for the microencapsulation of hen egg yolk immunoglobulin with pH-sensitive polymers
|
KR20010073460A
|
|
Process for the preparation 1,3-benzodithiol-2-ylium tetrafluoroborate
|
KR20010073294A
|
|
Method for preparing 4-hydroxy cumarin intermediate useful as anticoagulant rodenticide
|
KR20000057013A
|
|
Novel Intermediates, process for preparing macrolide antibiotic agent therefrom
|
KR20010029209A
|
|
Insulin Polymerization by Microbial Transglutaminase
|
KR20000065691A
|
|
Process for the preparation of terbinafine as an antifungal agent
|
KR20000055522A
|
|
Process for the preparation of imipenem
|